Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cardiovascular Systems Inc receives FDA clearance for low profile, 60cm diamondback devices designed to expand the treatment of peripheral artery disease


Monday, 10 Mar 2014 08:00am EDT 

Cardiovascular Systems Inc:Says it has received FDA clearance of its new Diamondback 360((reg))60cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial disease (PAD).CSI's new Diamondback Peripheral 60cm systems are available in two crown designs, the 1.25mm Micro Crown, and the 1.25mm Solid Crown. 

Company Quote

30.47
1.42 +4.89%
26 Nov 2014